Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House Panel Approves FDA Funding Bill With $6 Mil. Cut For Device Programs

This article was originally published in The Gray Sheet

Executive Summary

The House Appropriations Committee approved the fiscal year 2013 Agriculture/FDA funding bill June 19, including $317 million in appropriations for device oversight activities, $2 million shy of what the counterpart Senate committee passed in April.

You may also be interested in...

FDA Proposes 510(k) Requirements For Tanning Beds

The agency issued a proposed order reclassifying tanning beds from class I to class II with 510(k) requirements, and is proposing strict warnings against use in children under age 18.

Sequestration Threat Looms For 2013 Health Care Spending

A report from Sen. Tom Harkin states that impending across-the-board cuts would lead to major NIH grants reduction, in addition to significant spending cuts for cancer and HIV screening.

Senate Panel Approves FDA Appropriations, With Strong Words On Agency IT Systems

The Senate Appropriations Committee approves a $3.9 billion budget for the agency in fiscal 2013, including $319 million in federal funding for device activities.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts